Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
March 3, 2026
Clinical Decision-Making in Hematopoietic Cell Transplantation (HCT) for Severe Aplastic Anemia (SAA): Insights from a National Survey of Physicians
AB
Azra Borogovac
City of Hope
YE
Yvonne Efebera
OhioHealth
LC
LG Clark
Aplastic Anemia and MDS International Foundation
Ver todo
Puntos clave
Decision-making strategies for hematopoietic cell transplantation vary significantly among physicians, highlighting inconsistencies in treatment.
The survey included responses from over 300 physicians, providing a broad perspective on current practices.
Analysis of current trends reveals gaps in knowledge and protocol adherence in treating severe aplastic anemia.
Insights from the survey may enable better understanding and improvement in clinical practices for hematopoietic cell transplantation.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Borogovac et al. (Sun,) studied this question.
synapsesocial.com/papers/69a76091c6e9836116a2d723
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.460
Clinical Decision-Making in Hematopoietic Cell Transplantation (HCT) for Severe Aplastic Anemia (SAA): Insights from a National Survey of Physicians | Synapse